Woman with portable signs and application
Source: Signs
Food and medication administration approved on Wednesday the first glucose monitoring system specifically to lose weight of the starting signs, establishing a new option for Americans to control their weight.
The current treatment options for losing weight (popular medicines such as LPG-1 and surgical interventions are usually limited to patients with obesity or certain BMI. Obesity drugs such as Novo NordiskSgovy and Eli LillyThe Zepbound can also be difficult to access due to its high costs, a limited insurance coverage of the USA and a restricted supply.
But now, any patient can buy signs membership to access their system. Use an AI and a continuous glucose monitor, or CGM. Dexcom To offer personalized and real -time data and lifestyle recommendations for weight control.
“Now there is a solution that everyone can use to help on the weight loss trip, and it does not have to be a certain number of pounds to use it. It is available to the average American that needs it,” said Sharam Fouladgar-Melcer, co-founder and CEO of signs, in an interview on Tuesday before approval. “The average person could have five pounds to lose, or others could have 100 pounds to lose. We are here to help them at any time of that trip.”
The obesity epidemic costs the United States Medical Care System more than $ 170 billion a year, according to data from disease control and prevention centers. Almost 74% of Americans have overweight or obesity, say government data. Signs expects to make a “great dent in that curve for the improvement of many of us,” said Fouladgar-Mercer.
Customers who are registered in signs can choose a three -month or six months plan, which currently costs $ 139 and $ 129, respectively. The company will send all the CGM that a patient needs for the number of months in the plan they choose.
Currently, insurers do not cover the weight management system, but the plans are a monthly price fraction of approximately $ 1,000 of the LPG-1 in the US signs. UU. It is working with health insurance companies and employers to obtain coverage for the system, the company said in a statement to CNBC. Signs said he hopes that “this evolves rapidly as the interest in addressing the weight continued to expand.”
The signs system can be used in combination with LPG-1 or bariatric surgery, said Fouladgar-Mercer. He said patients can also use the system after leaving a LPG-1 to maintain their weight loss.
CGM are small sensors used at the top of the arm that track glucose levels, mainly for people with diabetes. This data is sent wirelessly to the application of signs, which also allows patients to record their food and exercise levels, among other information that the AI platform uses to make recommendations.
In addition to helping people lose pounds, the system aims to help users understand how their bodies respond to specific foods and exercise patterns and make correct behavior changes to handle and maintain their long -term weight.
The signs did not share how many patients are currently using their glucose monitoring system, but Fouladgar-Mercer said that tens of thousands of people have already tried it over time. He said that signs has expanded its CGM inventory and its software capacity to “handle a fairly massive scale” after approval.
